ArticleMolecular therapy oncolytics2020

oHSV2 Can Target Murine Colon Carcinoma by Altering the Immune Status of the Tumor Microenvironment and Inducing Antitumor Immunity.

Wen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.